Literature DB >> 8092764

The risk of endometrial cancer in diabetic and hypertensive patients: a nationwide record-linkage study in Finland.

J Maatela1, A Aromaa, T Salmi, M Pohja, M Vuento, M Grönroos.   

Abstract

The risk of endometrial cancer (EC) in diabetics and hypertensives was studied as part of the planning of a trial of the efficacy of screening for EC. Two nationwide registers, the Finnish Cancer Registry and the Social Insurance Institution's (SII) population register, were linked to obtain 1715 EC patients diagnosed during 1970-1974 with individually matched controls. Data on the right for state-reimbursed medication for diabetes or hypertension prior to the case's cancer diagnosis was obtained from the SII's population register and was used as indicator of the diseases in question. Diabetes was a strong and hypertension a relatively weak risk factor for EC. The relative risk for the association of EC with diabetes was 4.1 (95% confidence limits 2.7 and 6.9) and with hypertension 1.6 (95% confidence limits 1.3 and 2.1). Diabetics and hypertensives are identifiable risk groups for EC in Finland. Diabetics form a suitable target population for a trial of the efficacy of screening for EC.

Entities:  

Mesh:

Year:  1994        PMID: 8092764

Source DB:  PubMed          Journal:  Ann Chir Gynaecol Suppl        ISSN: 0355-9874


  8 in total

Review 1.  Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment.

Authors:  B Andersson
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

Review 2.  Metformin effects revisited.

Authors:  P Andújar-Plata; X Pi-Sunyer; B Laferrère
Journal:  Diabetes Res Clin Pract       Date:  2011-10-14       Impact factor: 5.602

3.  Impact of Insulin Therapies on Cancer Incidence in Type 1 and Type 2 Diabetes: A Population-Based Cohort Study in Reggio Emilia, Italy.

Authors:  Massimo Vicentini; Paola Ballotari; Francesco Venturelli; Marta Ottone; Valeria Manicardi; Marco Gallo; Marina Greci; Mirco Pinotti; Annamaria Pezzarossi; Paolo Giorgi Rossi
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

4.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis.

Authors:  E Friberg; N Orsini; C S Mantzoros; A Wolk
Journal:  Diabetologia       Date:  2007-05-03       Impact factor: 10.122

5.  Relationships of uterine and ovarian tumors to pre-existing chronic conditions.

Authors:  Louise A Brinton; Lori C Sakoda; Kirsten Frederiksen; Mark E Sherman; Susanne K Kjaer; Barry I Graubard; Jorgen H Olsen; Lene Mellemkjaer
Journal:  Gynecol Oncol       Date:  2007-09-07       Impact factor: 5.482

Review 6.  Metabolic syndrome and endometrial cancer: a meta-analysis.

Authors:  Katherine Esposito; Paolo Chiodini; Annalisa Capuano; Giuseppe Bellastella; Maria Ida Maiorino; Dario Giugliano
Journal:  Endocrine       Date:  2013-05-03       Impact factor: 3.633

7.  Endometrial Cancer Risk Prediction According to Indication of Diagnostic Hysteroscopy in Post-Menopausal Women.

Authors:  Carlo Saccardi; Amerigo Vitagliano; Matteo Marchetti; Alice Lo Turco; Sofia Tosatto; Michela Palumbo; Luciana Serena De Lorenzo; Salvatore Giovanni Vitale; Marco Scioscia; Marco Noventa
Journal:  Diagnostics (Basel)       Date:  2020-04-27

8.  A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer.

Authors:  Samantha L Bowker; Sheri L Pohar; Jeffrey A Johnson
Journal:  Health Qual Life Outcomes       Date:  2006-03-22       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.